Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decolonization of Staphylococcus aureus carriers before cardiac surgery
2018-001505-90Phase 4Completed
- Sponsor
- CHU Saint-Etienne
- Start
- Jun 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of mupirocin, hexetidine and chlorhexidine in Staphylococcus aureus nasal carriage, Staphylococcus aureus infection and surgical site infection (SSI), sponsored by CHU Saint-Etienne. Started Jun 2018; status: completed.
02
Drugs
mupirocinhexetidinechlorhexidine
03
Conditions
Staphylococcus aureus nasal carriageStaphylococcus aureus infectionsurgical site infection (SSI)
Beyond the preview
Go deeper on 2018-001505-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001505-90.